| http://www.w3.org/ns/prov#value | - 20110200531TREATMENT AND DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISORDERS - The invention relates to the use of tetramethylpyrazine (TMP) for the treatment of patients at risk for the development of, or diagnosed as having, CNS disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), glaucoma, and Huntington's Disease (HD), as well as traumatic brain injury (TBI).
|
